| Prevalence of multiple sclerosis in Isfahan, Iran M Etemadifar, M Janghorbani, V Shaygannejad, F Ashtari Neuroepidemiology 27 (1), 39-44, 2006 | 243 | 2006 |
| Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial Z Nikoo, S Badihian, V Shaygannejad, N Asgari, F Ashtari Journal of neurology 264 (9), 2003-2009, 2017 | 228 | 2017 |
| Effects of adjunct low‐dose vitamin d on relapsing‐remitting multiple sclerosis progression: preliminary findings of a randomized placebo‐controlled trial V Shaygannejad, M Janghorbani, F Ashtari, H Dehghan Multiple sclerosis international 2012 (1), 452541, 2012 | 119 | 2012 |
| Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study V Shaygannejad, M Janghorbani, A Ghorbani, F Ashtary, N Zakizade, ... Headache: The Journal of Head and Face Pain 46 (4), 642-648, 2006 | 115 | 2006 |
| A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke F Ashtary, M Janghorbani, A Chitsaz, M Reisi, A Bahrami Neurology 66 (6), 914-916, 2006 | 105 | 2006 |
| A double‐blind, randomized trial of low‐dose topiramate vs propranolol in migraine prophylaxis F Ashtari, V Shaygannejad, M Akbari Acta neurologica scandinavica 118 (5), 301-305, 2008 | 96 | 2008 |
| Sexual dysfunction in women with multiple sclerosis: Dimensions and contributory factors F Ashtari, R Rezvani, H Afshar Journal of research in medical sciences: the official journal of Isfahan …, 2014 | 94 | 2014 |
| Retinal optical coherence tomography in neuromyelitis optica FC Oertel, S Specovius, HG Zimmermann, C Chien, S Motamedi, ... Neurology: Neuroimmunology & Neuroinflammation 8 (6), e1068, 2021 | 85 | 2021 |
| Effects of rivastigmine on memory and cognition in multiple sclerosis V Shaygannejad, M Janghorbani, F Ashtari, HA Zanjani, N Zakizade Canadian journal of neurological sciences 35 (4), 476-481, 2008 | 84 | 2008 |
| Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial F Ashtari, N Toghianifar, SH Zarkesh-Esfahani, M Mansourian Neuroimmunomodulation 22 (6), 400-404, 2015 | 79 | 2015 |
| Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study V Shaygannejad, M Janghorbani, F Ashtari, H Zakeri Neurological research 34 (9), 854-858, 2012 | 78 | 2012 |
| Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial N Toghianifar, F Ashtari, SH Zarkesh-Esfahani, M Mansourian Journal of neuroimmunology 285, 125-128, 2015 | 71 | 2015 |
| Effect of extracorporeal shock wave therapy on lower limb spasticity in stroke patients P Taheri, B Vahdatpour, M Mellat, F Ashtari, M Akbari Archives of Iranian medicine 20 (6), 338-343, 2017 | 68 | 2017 |
| Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: the first report from Iran M Barzegar, S Badihian, O Mirmosayyeb, F Ashtari, M Jamadi, S Emami, ... Multiple sclerosis and related disorders 22, 161-165, 2018 | 66 | 2018 |
| An 8-year study of people with multiple sclerosis in Isfahan, Iran: association between environmental air pollutants and severity of disease F Ashtari, N Esmaeil, M Mansourian, P Poursafa, O Mirmosayyeb, ... Journal of neuroimmunology 319, 106-111, 2018 | 55 | 2018 |
| Longitudinal retinal changes in MOGAD FC Oertel, ES Sotirchos, HG Zimmermann, S Motamedi, S Specovius, ... Annals of Neurology 92 (3), 476-485, 2022 | 54 | 2022 |
| Diagnosis and treatment of multiple sclerosis M Etemadifar, F Ashtari Isfahan: Chaharbagh Publication 9, 2002 | 53 | 2002 |
| Fear and anxiety in patients with multiple sclerosis during COVID-19 pandemic; report of an Iranian population N Ramezani, F Ashtari, EA Bastami, K Ghaderi, SM Hosseini, MK Naeini, ... Multiple Sclerosis and Related Disorders 50, 102798, 2021 | 51 | 2021 |
| High dose Vitamin D intake and quality of life in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial F Ashtari, N Toghianifar, SH Zarkesh-Esfahani, M Mansourian Neurological Research 38 (10), 888-892, 2016 | 50 | 2016 |
| Multiple sclerosis national registry system in Iran: validity and reliability of a minimum data set S Shahin, S Eskandarieh, AN Moghadasi, N Razazian, SM Baghbanian, ... Multiple sclerosis and related disorders 33, 158-161, 2019 | 46 | 2019 |
